Karuna Therapeutics Management
Management criteria checks 1/4
Karuna Therapeutics' CEO is Bill Meury, appointed in Jan 2023, has a tenure of 1.08 years. directly owns 0.027% of the company’s shares, worth MX$57.07M. The average tenure of the management team and the board of directors is 1 years and 4.3 years respectively.
Key information
Bill Meury
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Bill Meury (55 yo)
1.1yrs
Tenure
Mr. William Meury, also known as Bill, served as a Partner at Hildred Capital Management LLC. He serves as Director at Crown Laboratories Inc and serves as its Chairman of the Board of Directors. He curren...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder and President of Research & Development | no data | US$5.77m | 0.037% MX$ 77.1m | |
| Chief Medical Officer | 6.9yrs | US$4.41m | 0.089% MX$ 185.5m | |
| President | 1.1yrs | no data | 0.027% MX$ 57.1m | |
| Chief Financial Officer | less than a year | no data | 0.037% MX$ 77.3m | |
| Vice President of Corporate Affairs & Investor Relations | no data | no data | no data | |
| General Counsel | 4.1yrs | no data | no data | |
| Senior Vice President of Corporate Development | less than a year | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Chair of Scientific Advisory Board & Chief Clinical Advisor | no data | no data | no data | |
| Senior Vice President of Medical | 3.1yrs | no data | no data | |
| Chief Commercial Officer | less than a year | no data | no data |
1.0yrs
Average Tenure
60yo
Average Age
Experienced Management: KRTX *'s management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | no data | 0.027% MX$ 57.1m | |
| Chair of Scientific Advisory Board & Chief Clinical Advisor | no data | no data | no data | |
| Independent Director | 4.7yrs | US$336.10k | 0.086% MX$ 179.4m | |
| Director | 5.3yrs | US$326.60k | 0% MX$ 0 | |
| Member of Scientific Advisory Board | 3.2yrs | US$701.26k | no data | |
| Chairman | 3.8yrs | US$373.15k | 0% MX$ 0 | |
| Director & Member of Scientific Advisory Board | 5.9yrs | US$11.22m | 0.29% MX$ 612.0m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director & Member of Scientific Advisory Board | 4.7yrs | US$344.60k | 0% MX$ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.5yrs | US$345.10k | 0% MX$ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
4.3yrs
Average Tenure
69yo
Average Age
Experienced Board: KRTX *'s board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/25 04:08 |
| End of Day Share Price | 2023/11/28 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Karuna Therapeutics, Inc. is covered by 20 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Caroline Palomeque | Berenberg |
| Esther Lannie Hong | Berenberg |
| Jason Matthew Gerberry | BofA Global Research |